Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

Caffeine improves hair growth, thickness, and reduces shedding.

Lisinopril, a heart medication, probably caused hair loss in a patient, which stopped after switching drugs.

A complex of 5-aminolevulinic acid and glycyl-histidyl-lysine peptide may help increase hair count in male pattern hair loss without side effects.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

Androgens can both increase body hair and cause scalp hair loss.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

A herbal extract may help treat certain types of hair loss by reducing a specific gene's activity.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Hair transplantation can successfully treat stubborn alopecia areata.

A woman with both TLE and SLE improved with hydroxychloroquine treatment.

Many survivors of critical illness, especially those with sepsis, experience hair loss.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

A woman had temporary hair loss after a facelift, which improved on its own within a year.

A woman's hair changed to a dry, tangled texture that's hard to comb after treatment with spironolactone, suggesting the medication might cause such hair changes.

Hair graying is influenced by factors like nerves, fat cells, and immune cells, not just hair follicles.

Low-level laser therapy did not reduce licking or improve lesions in dogs with ALD but did increase hair growth.

Hair mesotherapy might help with certain types of hair loss but lacks strong scientific proof and has some risks.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

Secondary amenorrhea has many causes and requires thorough evaluation to treat and restore menstrual cycles.

Case reports are important in medical science for discovering drugs and identifying rare conditions, despite their limitations.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

A new hair loss classification for women improves treatment, but careful patient selection is crucial for successful hair transplantation.

LAAM caused developmental toxicity in tolerant rats without causing birth defects.

Zinc made mice's coarse hair turn into fine hair without affecting skin structure.

Pharmacists should interpret lab data and perform physical exams to improve patient care.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.